Back to search
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Metastatic Non-small Cell Lung Cancer With MTAP Deletion trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Metastatic Non-small Cell Lung Cancer With MTAP Deletion trials you may qualify forThe purpose of this study is to compare the clinical benefit of the combination of BMS-986504 (a selective MTA-cooperative inhibitor of PRMT5) plus pembrolizuma…
The purpose of this study is to evaluate the safety and efficacy of BMS-986504 monotherapy in participants with advanced or metastatic Non-small Cell Lung Cance…
TNG462-C102 is a Phase 1/2, open-label, multicenter study designed to determine the safety, tolerability, PK, PD, and preliminary antineoplastic activity of ora…
This is a first-in-human Phase 1/2, multicenter, open-label study of S095035 as single-agent, or in combination with TNG462 in adult participants with advanced…
This is a multicenter clinical study to evaluate the safety, efficacy, and Pharmacokinetics (PK) of IDE892 as monotherapy and in combination with other agents i…